Professor innovating in the area of cancer biology and genetics, Dr. F. Kay Huebner is a distinguished Professor Emerita at The Ohio State University College of Medicine. Her academic journey began with a PhD in Microbiology from the University of Pennsylvania, followed by postdoctoral training in Molecular Genetics at The Wistar Institute Cancer Center. Dr. Huebner's research is deeply rooted in the exploration of tumor suppressor proteins, with a particular focus on Fhit and Wwox, and their roles in the pathogenesis of various cancers. Dr. Huebner's work is pivotal in the field of cancer research, as she employs advanced molecular genetic techniques to unravel the complexities of tumor biology. Her investigations are primarily centered on breast, pancreas, and lung cancers, where she seeks to understand the underlying mechanisms that drive these malignancies. Through her research, she aims to identify novel prognostic markers that can aid in the early detection and treatment of cancer. Her contributions to the field extend beyond basic research, as she is also dedicated to translating her findings into potential therapeutic targets. By understanding the biological functions of tumor suppressor proteins, Dr. Huebner hopes to develop innovative strategies for cancer treatment, ultimately improving patient outcomes. Throughout her career, Dr. Huebner has been recognized for her groundbreaking work in cancer genetics. Her research has been published in numerous peer-reviewed journals, and she has been invited to speak at international conferences, where she shares her insights and advances in the field. In addition to her research, Dr. Huebner has been a mentor to many students and young scientists, fostering the next generation of researchers in cancer biology. Her commitment to education and research excellence continues to inspire those around her, making her a respected figure in the scientific community.